Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy

Brain

Volumn 134, Issue 11, 2011, Pages 3185-3197

  Farrar, Michelle A ^a,b   Vucic, Steve ^a,c   Lin, Cindy S Y ^a,b   Park, Susanna B ^a,d   Johnston, Heather M ^b   Du Sart, Desirée ^e   Bostock, Hugh ^f   Kiernan, Matthew C ^a,d  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

axon; excitability; spinal muscular atrophy

Indexed keywords

POTASSIUM ION; SODIUM ION;

ADAPTATION; ADOLESCENT; ADULT; ARTICLE; BIOPHYSICS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; HYPERPOLARIZATION; MALE; MOTOR NERVE; MOTOR PERFORMANCE; MUSCLE ACTION POTENTIAL; NERVE CELL MEMBRANE CONDUCTANCE; NERVE EXCITABILITY; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NERVE STIMULATION; NEUROPHYSIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY;

EID: 81055144436     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr229     Document Type: Article

References (68)

1. Baker M, Bostock H, Grafe P, Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol 1987; 383: 45-67. (Pubitemid 17020327)
2. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982; 323: 117-44. (Pubitemid 12180900)
3. Boland RA, Bostock H, Kiernan MC. Plasticity of lower limb motor axons after cervical cord injury. Clin Neurophysiol 2009; 120: 204-9.
4. Bostock H. The strength-duration relationship for excitation of myelin-ated nerve: computed dependence on membrane parameters. J Physiol 1983; 341: 59-74. (Pubitemid 13028523)
5. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997; 498(Pt 1): 277-94. (Pubitemid 27056895)
6. Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 1991; 441: 537-57.
7. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58. (Pubitemid 28079733)
8. Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995; 118: 217-25.
9. Bowerman M, Beauvais A, Anderson CL, Kothary R. Rho-kinase inacti-vation prolongs survival of an intermediate SMA mouse model. Hum Mol Genet 2010; 19: 1468-78.
10. Bromberg MB, Swoboda KJ. Motor unit number estimation in infants and children with spinal muscular atrophy. Muscle Nerve 2002; 25: 445-7. (Pubitemid 34203224)
11. Bromberg MB, Swoboda KJ, Lawson VH. Counting motor units in chronic motor neuropathies. Exp Neurol 2003; 184(Suppl. 1): S53-7. (Pubitemid 37338704)
12. Cheah BC, Vucic S, Krishnan AV, Kiernan MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 2010; 17: 1942-199.
13. Chien YY, Nonaka I. Peripheral nerve involvement in Werdnig-Hoffmann disease. Brain Dev 1989; 11: 221-9. (Pubitemid 19203508)
14. Elsheikh B, Prior T, Zhang X, Miller R, Kolb SJ, Moore D, et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve 2009; 40: 652-6.
15. Farrar MA, Johnston HM, Grattan-Smith P, Turner A, Kiernan MC. Spinal muscular atrophy: molecular mechanisms. Curr Mol Med 2009; 9: 851-62.
16. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358-68. (Pubitemid 34112291)
17. Fox DA, Ruan DY. Time-and frequency-dependent effects of potassium channel blockers on large and medium diameter optic tract axons. Brain Res 1989; 498: 229-42. (Pubitemid 19228188)
18. Galea V, Fehlings D, Kirsch S, McComas A. Depletion and sizes of motor units in spinal muscular atrophy. Muscle Nerve 2001; 24: 1168-72. (Pubitemid 32762144)
19. Hausmanowa-Petrusewicz I, Karwanacuteska A. Electromyographic findings in different forms of infantile and juvenile proximal spinal muscular atrophy. Muscle Nerve 1986; 9: 37-46. (Pubitemid 16076350)
20. Ibrahim M, Butt AM, Berry M. Relationship between myelin sheath diameter and internodal length in axons of the anterior medullary velum of the adult rat. J Neurol Sci 1995; 133: 119-27.
21. Kaji R. Physiological and technical basis of peripheral nerve and moto-neurons testing. In: Kimura J, Kaji R, editors. Physiology of ALS and related diseases. Amsterdam: Elsevier; 1997. p. 15-41.
22. Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003; 126: 965-73. (Pubitemid 36372993)
23. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006; 129: 953-62.
24. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123 (Pt 12): 2542-51.
25. Kiernan MC, Mogyoros I, Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 1996; 119(Pt 4): 1099-105. (Pubitemid 26300712)
26. Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain 2001; 124: 816-25. (Pubitemid 32303839)
27. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409. (Pubitemid 30126986)
28. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005; 57: 339-48. (Pubitemid 40343955)
29. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011; 377: 942-55.
30. Krishnan AV, Kiernan MC. Altered nerve excitability properties in established diabetic neuropathy. Brain 2005; 128: 1178-87. (Pubitemid 40675471)
31. Kuo JJ, Siddique T, Fu R, Heckman CJ. Increased persistent Na( +) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 2005; 563: 843-54. (Pubitemid 40425599)
32. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997; 16: 265-9. (Pubitemid 27280210)
33. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155-65.
34. Lewelt A, Krosschell KJ, Scott C, Sakonju A, Kissel JT, Crawford TO, et al. Compound muscle action potential and motor function in children with spinal muscular atrophy. Muscle Nerve 2010; 42: 703-8.
35. Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002; 4: 20-6. (Pubitemid 44698460)
36. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411-22. (Pubitemid 27258073)
37. Medical Research Council MR. Aid to the examination of the peripheral nervous system. London: Her Majesty's Stationary Office 1976.
38. Mentis GZ, Blivis D, Liu W, Drobac E, Crowder ME, Kong L, et al. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 2011; 69: 453-67.
39. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996; 119(Pt 2): 439-47. (Pubitemid 26149359)
40. Mogyoros I, Kiernan MC, Burke D, Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998; 121(Pt 5): 851-9. (Pubitemid 28220893)
41. Moldovan M, Alvarez S, Krarup C. Motor axon excitability during Wallerian degeneration. Brain 2009; 132: 511-23.
42. Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2: 423-8. (Pubitemid 23104723)
43. Murray LM, Lee S, Baumer D, Parson SH, Talbot K, Gillingwater TH. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010; 19: 420-33.
44. Nakata M, Baba H, Kanai K, Hoshi T, Sawai S, Hattori T, et al. Changes in Na(+ ) channel expression and nodal persistent Na(+ ) currents associated with peripheral nerve regeneration in mice. Muscle Nerve 2008; 37: 721-30. (Pubitemid 351821899)
45. Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asanuma K, Jia-Ying S, et al. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain 2004; 127: 203-11. (Pubitemid 38055359)
46. Press W, Teukolsky S, Vetterling W, Flannery B. Numerical recipes in C-The art of computing. Cambridge: Cambridge University press; 1992.
47. Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 2009; 85: 408-13.
48. Ritchie JM. Sodium and potassium channels in regenerating and developing mammalian myelinated nerves. Proc R Soc Lond B Biol Sci 1982; 215: 273-87. (Pubitemid 12024801)
49. Russman BS, Iannaccone ST, Samaha FJ. A phase 1 trial of riluzole in spinal muscular atrophy. Arch Neurol 2003; 60: 1601-3. (Pubitemid 37443126)
50. Sawai S, Kanai K, Nakata M, Hiraga A, Misawa S, Isose S, et al. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration. Clin Neurophysiol 2008; 119: 1097-105.
51. Schwarz JR, Reid G, Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch 1995; 430: 283-92.
52. Shibuta Y, Nodera H, Mori A, Okita T, Kaji R. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy. J Clin Neurophysiol 2010; 27: 350-7.
53. Smith M, Calabro V, Chong B, Gardiner N, Cowie S, du Sart D. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet 2007; 15: 759-66. (Pubitemid 46965409)
54. Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol 2005; 57: 704-12. (Pubitemid 40628859)
55. Swoboda KJ, Scott CB, Reyna SP, Prior TW, LaSalle B, Sorenson SL, et al. Phase II open label study of valproic acid in spinal muscular atrophy. PLoS One 2009; 4: e5268.
56. Tomlinson S, Burke D, Hanna M, Koltzenburg M, Bostock H. In vivo assessment of HCN channel current (I(h)) in human motor axons. Muscle Nerve 2010a; 41: 247-56.
57. Tomlinson SE, Tan SV, Kullmann DM, Griggs RC, Burke D, Hanna MG, et al. Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. Brain 2010b; 133: 3530-40.
58. Trevillion L, Howells J, Burke D. Outwardly rectifying deflections in threshold electrotonus due to K + conductances. J Physiol 2007; 580: 685-96. (Pubitemid 46564192)
59. Urbani A, Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 2000; 12: 3567-74.
60. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006; 117: 1458-66. (Pubitemid 43947716)
61. Vucic S, Kiernan MC. Pathophysiologic insights into motor axonal function in Kennedy disease. Neurology 2007; 69: 1828-35. (Pubitemid 350071143)
62. Waxman SG, Ritchie JM. Molecular dissection of the myelinated axon. Ann Neurol 1993; 33: 121-36. (Pubitemid 23039921)
63. Weihl CC, Connolly AM, Pestronk A. Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. Neurology 2006; 67: 500-1. (Pubitemid 44214981)
64. Weiss G. On the possibility to make mutually comparable devices serving for electrical excitation. Arch Ital Biol 1901; 35: 413-46.
65. Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik-Schoneborn S, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999; 64: 1340-56. (Pubitemid 30468752)
66. Yang Q, Kaji R, Hirota N, Kojima Y, Takagi T, Kohara N, et al. Effect of maturation on nerve excitability in an experimental model of threshold electrotonus. Muscle Nerve 2000; 23: 498-506. (Pubitemid 30164774)
67. Zhang HL, Pan F, Hong D, Shenoy SM, Singer RH, Bassell GJ. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 2003; 23: 6627-37. (Pubitemid 36909889)
68. Zhang Z, Lotti F, Dittmar K, Younis I, Wan L, Kasim M, et al. SMN Deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 2008; 133: 585-600. (Pubitemid 351636302)